These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1035374)

  • 1. [A study on tumor of the bladder: clinical and prognostic studies on 426 cases (author's transl)].
    Niijima T; Matsumura Y; Katayama Y; Morinaga O; Ike N
    Nihon Hinyokika Gakkai Zasshi; 1976 Dec; 67(12):1057-63. PubMed ID: 1035374
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the therapy of malignant bladder tumours (author's transl)].
    Eberhardt HJ; Liebscher J; Raatssch H; Günther J
    Radiobiol Radiother (Berl); 1973; 14(4):345-53. PubMed ID: 4771071
    [No Abstract]   [Full Text] [Related]  

  • 3. Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection.
    Chang WC; Chang YH; Pan CC
    Am J Surg Pathol; 2012 Mar; 36(3):454-61. PubMed ID: 22261706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large nested variant of urothelial carcinoma: 23 cases mimicking von Brunn nests and inverted growth pattern of noninvasive papillary urothelial carcinoma.
    Cox R; Epstein JI
    Am J Surg Pathol; 2011 Sep; 35(9):1337-42. PubMed ID: 21836490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A study of 200 cases of bladder cancer: relation of pathological characteristics to prognosis (author's transl)].
    Matsumura Y; Niijima T
    Nihon Hinyokika Gakkai Zasshi; 1977 Jan; 68(1):1-10. PubMed ID: 557691
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pathological-anatomical analysis of 630 bladder tumor biopsies with special emphasis on the potential malignancy of bladder papillomas (author's transl)].
    Bettendorf U
    Urologe A; 1974 Mar; 13(2):56-8. PubMed ID: 4832066
    [No Abstract]   [Full Text] [Related]  

  • 7. Superficial TCC bladder cancer: the impact of tumor differentiation on recurrence, progression and survival.
    Kurth KH
    Prog Clin Biol Res; 1984; 162A():307-18. PubMed ID: 6483914
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: impact of patient age on outcome following bladder-preserving treatment for non-muscle-invasive bladder cancer.
    Griebling TL
    J Urol; 2011 Feb; 185(2):466-7. PubMed ID: 22088624
    [No Abstract]   [Full Text] [Related]  

  • 9. The results of treatment of 1,475 patients with bladder carcinoma in the region of Amsterdam, The Netherlands.
    Rasker FM
    Prog Clin Biol Res; 1988; 260():347-56. PubMed ID: 3362892
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experimental and clinical studies on bladder cancer: clinical evaluation of partial cystectomy (author's transl)].
    Mishina T; Watanabe K; Miyakoda K; Araki H; Fujiwara T
    Nihon Hinyokika Gakkai Zasshi; 1977 Jul; 68(7):678-85. PubMed ID: 916449
    [No Abstract]   [Full Text] [Related]  

  • 11. Does muscularis mucosae invasion in extensively lamina propria-invasive high-grade papillary urothelial carcinoma provide additional prognostic information?
    Pan CC
    Am J Surg Pathol; 2013 Mar; 37(3):459-60. PubMed ID: 23388127
    [No Abstract]   [Full Text] [Related]  

  • 12. [Transurethral resection of bladder tumors--indication, technique and results (author's transl)].
    Mauermayer W; Tauber R
    Urologe A; 1977 May; 16(3):185-9. PubMed ID: 878114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The inverted papilloma of the urinary bladder (author's transl)].
    Donhujsen K; Leistenschneider W
    Zentralbl Allg Pathol; 1976; 120(5):413-6. PubMed ID: 1014969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of 90 step-sectioned cystectomized specimens of bladder cancer.
    Kakizoe T; Matsumoto K; Nishio Y; Kishi K
    J Urol; 1984 Mar; 131(3):467-72. PubMed ID: 6699986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SNAI1 protein expression is an independent negative prognosticator in muscle-invasive bladder cancer.
    Keck B; Wach S; Goebell PJ; Kunath F; Bertz S; Lehmann J; Stöckle M; Taubert H; Wullich B; Hartmann A
    Ann Surg Oncol; 2013 Oct; 20(11):3669-74. PubMed ID: 23807662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The historical development of the staging of bladder tumors: personal reminiscences.
    Jewett HJ
    Urol Surv; 1977 Apr; 27(2):37-40. PubMed ID: 329533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The risk factors of bladder tumors stage "A". Description of a new parameter (author's transl)].
    Steg A; Allouch G; Deslignières S
    Sem Hop; 1980 Apr 18-25; 56(15-16):738-43. PubMed ID: 6246608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunological reactivity follow-up in patients with papillocarcinoma of the urinary bladder (author's transl)].
    Korcáková L; Pazourek J
    Cas Lek Cesk; 1979 Apr; 118(15):454-7. PubMed ID: 455362
    [No Abstract]   [Full Text] [Related]  

  • 19. [Histologic structure and spread of malignant neoplasms within the urinary bladder (author's transl)].
    Arndt J; Albert L; Kriester A
    Arch Geschwulstforsch; 1975; 45(2):173-9. PubMed ID: 1203022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Standards and perspectives in diagnosis and therapy of bladder carcinoma].
    Stief C; Zaak D; Stöckle M; Studer U; Knuechel R; Rödel C; Sauer R; Rubben H
    Urologe A; 2006 Sep; 45 Suppl 4():90-6. PubMed ID: 16896761
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.